Valganciclovir. Cymeval, RO 1079070/194, RS 079070194, RS 79070.
D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D017326:Clinical Trials, Phase III as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000077562:Valganciclovir
D000998:Antiviral Agents; D015507:Drugs, Investigational; D000077562:Valganciclovir; D015774:Ganciclovir